The Chandran Lab
  • home
  • news & media
  • research
  • team
  • publications
  • find us
  • positions
The Chandran Lab
  • home/
  • news & media/
  • research/
  • team/
  • publications/
  • find us/
  • positions/
endocytic trafficking sketch_09_no UVRAG_Arl8b.001.png
The Chandran Lab

research

The Chandran Lab
  • home/
  • news & media/
  • research/
  • team/
  • publications/
  • find us/
  • positions/
 

Start typing to search for blog entry:

 
 
 
May 26, 2015

Niemann-Pick C1 Is essential for ebolavirus replication and pathogenesis in vivo→

May 26, 2015/ Kartik Chandran
Niemann-Pick C1 Is essential for ebolavirus replication and pathogenesis in vivo

Herbert AS et al, MBio 2015

Read More
May 26, 2015/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, NPC1, pathogenesis, host, animal model, receptors, host factors, therapeutics, 2014–2015, antivirals, researchpage, 2015
August 20, 2014

Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge→

August 20, 2014/ Kartik Chandran
Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge

Chen G, Koellhoffer JF, Zak SE et al, ACS Chem Biol 2014

Read More
August 20, 2014/ Kartik Chandran/ Comment /Source
therapeutics, antibody, GP, pathogenesis, animal model, 2014–2015, filovirus, 2014
February 01, 2011

Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles→

February 01, 2011/ Kartik Chandran
Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles

Martinez O et al, J Infect Dis 2011

Read More
February 01, 2011/ Kartik Chandran/ Comment /Source
filovirus, Ebola virus, antibody, animal model, 2010–2011, 2011

© 2015, Kartik Chandran Laboratory